Carasent AB (CARA) Price & Analysis

Compare

0 Followers

CARA Stock Chart & Stats

kr29.00

-kr0.28(-1.22%)

At close: Mar 05 4:00 PM EST

kr29.00

-kr0.28(-1.22%)

Day’s Range― - ―

52-Week Rangekr19.60 - kr31.25

Previous CloseN/A

Volume42.56K

Average Volume (3M)175.33K

Market Cap

kr1.67B

Enterprise Valuekr1.48B

Total Cash (Recent Filing)kr254.79M

Total Debt (Recent Filing)kr35.32M

Price to Earnings (P/E)48.7

Beta0.01

Next Earnings

Apr 14, 2026

EPS Estimate

0.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.41

Shares Outstanding72,324,780

10 Day Avg. Volume229,351

30 Day Avg. Volume175,329

Financial Highlights & Ratios

PEG Ratio11.72

Price to Book (P/B)1.85

Price to Sales (P/S)6.00

P/FCF Ratio-320.44

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Recurring Revenue ModelA subscription-heavy business with implementation and support services creates predictable, recurring revenue and higher customer lifetime value. This model supports steady cash inflows, easier forecasting, and opportunities for cross-sell and upsell, underpinning long-term revenue visibility.

Consistent Revenue Growth & MarginsSustained revenue growth coupled with a strong gross margin indicates demand for products and efficient delivery. That mix supports reinvestment in R&D and market expansion while helping the company scale operating leverage once fixed costs are absorbed, benefiting multi-quarter resilience.

Conservative Leverage And Strong EquityA strong equity ratio and low leverage provide financial flexibility to weather downturns, fund strategic initiatives, or pursue M&A without excessive refinancing risk. Conservative balance sheet positioning reduces solvency risk and supports sustained investment in product and customer success.

Bears Say

Negative ProfitabilityPersistent negative net income and EBIT mean core operations are not yet generating sustainable profits. Over time this erodes retained earnings, limits internal funding for growth, and increases dependence on external capital unless operating margins improve materially.

Negative Free Cash FlowNegative free cash flow after capex indicates the business currently consumes capital to grow or maintain operations. If sustained, this can constrain investment, force dilution or debt raises, and reduce financial optionality, making long-term scaling more capital-intensive.

Negative Return On EquityA negative ROE shows the company is not producing returns on shareholder capital, which undermines long-term investor confidence and can complicate future fundraising. Improving operational efficiency and moving to positive ROE is essential for durable capital attractiveness.

Carasent AB News

Carasent Boosts Growth and Swings to Profit in 2025

An update from Carasent AB ( ($SE:CARA) ) is now available. Carasent AB reported strong full-year 2025 results,...

6d ago

CARA

Carasent to Present Q4 2025 Interim Results on 12 February

The latest announcement is out from Carasent AB ( ($SE:CARA) ). Carasent AB, a Swedish healthcare technology company...

9d ago

CARA

Carasent Nomination Committee Proposes Unchanged Board Line-Up for 2026 AGM

The latest update is out from Carasent AB ( ($SE:CARA) ). Carasent AB’s nomination committee has presented its...

12d ago

CARA

Carasent AB Increases Shareholding to Over 5%

Carasent AB ( ($SE:CARA) ) has issued an update. Carasent AB, a company involved in share trading and...

2M ago

CARA

Carasent AB Appoints 2026 Nomination Committee

An update from Carasent AB ( ($SE:CARA) ) is now available. Carasent AB has announced the appointment of...

4M ago

CARA

Carasent AB Launches SEK 150 Million Share Buy-Back Program

An update from Carasent AB ( ($SE:CARA) ) is now available. Carasent AB has announced a SEK 150...

7M ago

CARA

Carasent AB Revises 2025 Financial Targets Amid Organizational Changes

Carasent AB ( ($SE:CARA) ) just unveiled an update. Carasent AB has revised its financial targets for 2025,...

8M ago

CARA

Carasent AB to Present Q2 2025 Financial Results

An announcement from Carasent AB ( ($SE:CARA) ) is now available. Carasent AB has announced that it will...

8M ago

CARA

CARA FAQ

What was Carasent AB’s price range in the past 12 months?

Carasent AB lowest stock price was kr19.60 and its highest was kr31.25 in the past 12 months.

What is Carasent AB’s market cap?

Carasent AB’s market cap is kr1.67B.

When is Carasent AB’s upcoming earnings report date?

Carasent AB’s upcoming earnings report date is Apr 14, 2026 which is in 55 days.

How were Carasent AB’s earnings last quarter?

Carasent AB released its earnings results on Feb 12, 2026. The company reported kr0.41 earnings per share for the quarter, beating the consensus estimate of kr0.075 by kr0.335.

Is Carasent AB overvalued?

According to Wall Street analysts Carasent AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Carasent AB pay dividends?

Carasent AB pays a Notavailable dividend of kr1.84 which represents an annual dividend yield of N/A. See more information on Carasent AB dividends here

What is Carasent AB’s EPS estimate?

Carasent AB’s EPS estimate is 0.08.

How many shares outstanding does Carasent AB have?

Carasent AB has 72,324,780 shares outstanding.

What happened to Carasent AB’s price movement after its last earnings report?

Carasent AB reported an EPS of kr0.41 in its last earnings report, beating expectations of kr0.075. Following the earnings report the stock price went up 1.739%.

Which hedge fund is a major shareholder of Carasent AB?

Currently, no hedge funds are holding shares in SE:CARA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Carasent AB

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webdoc X, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.